Product Details

Seretide 50 mcg/250 mcg Diskus Inhalation Powder

Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)
250 mcg/Metered-Dose; 50 mcg/Metered-Dose
Inhalation powder

ROA

Inhalation, Oral

Applicant Name

GlaxoSmithKline Consumer Nigeria PLC (GSK)

NRN

04-3323

Status

Active


Composition

Each blister contains: Salmeterol as Salmeterol Xinafoate 50 mcg, Fluticasone Propionate 250 mcg  

ATC Code/ATCvet Code

R03AK06  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 60's (in blister)  

Product Description

Inhalation Powder

Manufacturer Name

GlaxoSmithKline LLC

Manufacturer Country

UNITED STATES OF AMERICA  

Approval Date

2023-07-06  

Expiry Date

2028-07-05